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This article describes the application and performance of an inexpensive, simple and portable device 
for colorimetric quantitative determination of drugs in pharmaceutical preparations. The sensor is a 
light detector resistor (LDR) incorporated into a black PTFE cell and coupled to a low-cost multimeter 
(Ohmmeter). Quantitative studies were performed with captopril/p-chloranil/H2O2 and methyldopa/
ammonium molybdate systems. Calibration curves were obtained by plotting the electrical resistance of 
the LDR against the concentration of the colored species in the ranges 1.84 × 10-4 to 1.29 × 10-3 mol L-1 
and 5.04 × 10-4 to 2.52 × 10-3 mol L-1 for captopril/p-chloranil/H2O2 and methyldopa/ammonium molybdate 
systems, respectively, exhibiting good coefficients of determination. Statistical analysis of the results 
obtained showed no significant difference between the proposed methodologies and the official reported 
methods, as evidenced by the t-test and variance ratio at a 95% confidence level. The results of this study 
demonstrate the applicability of the instrument for simple, accurate, precise, fast, in situ and low-cost 
colorimetric analysis of drugs in pharmaceutical products.
Uniterms: Optical sensor/application/colorimetric analysis. Instrumentation/drugs dosage. Drugs/
quantitative analysis. Drugs/dosage. Pharmaceutical formulations/quality control.
Este artigo descreve o desenvolvimento e a aplicação de um dispositivo portátil, simples e barato para 
a determinação colorimétrica quantitativa de fármacos em formulações farmacêuticas. O sensor é um 
resistor detector de luz (RDL) colocado numa célula de PTFE e acoplado a um multímetro de baixo custo. 
Os estudos quantitativos foram realizados utilizando captopril/p-cloranil/H2O2 e metildopa/molibdato de 
amônio como sistemas reacionais. As curvas de calibração foram obtidas através da representação gráfica 
da resistência elétrica do RDL contra a concentração dos complexos coloridos formados nas faixas de 
1,84 × 10-4 e 1,29 × 10-3 mol L-1 e 5,04 × 10-4 e 2,52 × 10- 3 mol L-1 para captopril/p-cloranil/H2O2 e de 
metildopa/molibdato de amônio, respectivamente, com bons coeficientes de determinação. As análises 
estatísticas dos resultados obtidos mostraram que não houve diferença significativa entre os métodos 
propostos e os métodos oficiais como evidente a partir dos testes “t-Student” e F-Fisher, com nível de 
confiança de 95%. Os resultados deste estudo demonstram que o instrumento proposto neste trabalho é 
simples, de fácil operação, baixo custo e apresentou boa exatidão e boa precisão para o doseamento de 
fármacos em medicamentos.
Unitermos: Sensor óptico/aplicação/análise colorimétrica. Instrumentação/doseamento de fármacos. 
Fármacos/análise quantitativa. Fármacos/doseamento. Formulações farmacêuticas/controle de qualidade.
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INTRODUCTION
Captopril, 1-[(2S)-3-mercapto-2-methylpropionyl]-
L-proline (Figure 1), (CPT) is an angiotensin-converting 
enzyme inhibitor, which reduces peripheral resistance 
and lowers blood pressure. It is extensively used for the 
treatment of hypertension (Florey, 1988) and congestive 
failure (Brunton, Chabner, Knollman, 2010).
In order to assure the quality of CPT containing 
pharmaceutical formulations, several analytical 
techniques have been used for determination of the 
drug, including batch fluorimetry (Hormozi-Nezhad 
et al., 2013), chemiluminescence (Zhang et al., 2009), 
high-performance liquid chromatography (Karakosta, 
Tzanavaras, Themelis, 2012), electrochemical methods 
(Jamali, Karimi-Maleh, Khalilzadeh, 2014; Ensafi et 
al., 2011; Karimi-Maleh, Ensafi, Allafchian, 2010; 
Khalilzadeh et al., 2010), volumetric titration (USP, 
2007), diffuse reflectance spectroscopy (Ribeiro; Pezza; 
Pezza, 2011) and spectrophotometry (Gouda, Amin, 2010; 
El-Didamony, Erfan, 2010; Ribeiro, Pezza; Pezza, 2010; 
Ribeiro et al., 2011; Silva, Matos, Ribeiro, 2014).
Methyldopa, α-methyl-3,4-dihydroxyphenylalanine 
(Figure 2), (MTD) is a catechol derivative (catecholamine) 
widely used as a antihypertensive agent. It is a centrally 
acting alpha2-adrenoreceptor agonist, which reduces 
sympathetic tone and produces a decrease in blood 
pressure (Brunton, Chabner, Knollman, 2010).
Several types of analytical procedures have been 
employed for the analysis of MTD in pharmaceutical 
formulations and/or biological samples. Of the techniques 
used in several procedures most are based on kinetic 
measurements (James; Hoo; William, 2006), high-
performance liquid chromatography (Bahrami, Kiani, 
Mirzaeei, 2006; Muzzi et al., 2008; Li et al., 2010), 
voltammetry (Rezaei, Askarpour, Ensafi, 2013), 
spectrophotometry (Gadkariem et al., 2009; Brasil, 
2010; Matos,Silva; Ribeiro, 2012; Ribeiro, Pezza, Pezza, 
2005; Ribeiro, 2005) and diffuse reflectance spectroscopy 
(Ribeiro, Pezza, Pezza, 2006).
However, some of these methods are inherently 
expensive, time consuming, laborious and not well 
suited for process control monitoring. In addition, 
chromatographic methods are slow and require expensive 
and complicated instrumentation, features rendering 
them unattractive for routine analysis. The titrimetric 
method can suffer from a lack of specificity and sensitivity 
under certain circumstances, such as in the presence of 
unsaturated organic compounds. The proposed approach 
is relatively reliable, low cost and sufficiently compact 
to be applied even by untrained personnel. Thus, there is 
considerable interest in the development of highly reliable, 
cost effective, sensitive, and selective detection devices 
for determination of CPT and MTD in marketed dosage 
formulations.
Instrumentation has become integral to chemical 
measurements. A multimeter is an essential piece of 
equipment on an electrician´s workbench. It is a universal 
instrument, useful not only for measuring electrical 
quantities, such as voltage, current, and resistance, but also 
for testing electrical and electronic circuits. 
Thus,  the multimeter could also be a very 
useful instrument for the chemistry laboratory bench. 
Contemporary electronics and instrumentation 
have reached a level of application that allows the 
measurement, direct or indirect, of chemical quantities. 
These measurements involve the encoding of chemical 
information into electrical signals. This transduction 
can be carried out through a variety of physical and 
chemical principles, and in most cases, the resultant 
electrical quantity can be measured using a multimeter. 
Colorimetric (Acharya, Jayaraman, 1995; Richter, Rocha, 
Angnes, 2004; Rossi, He, Tubino, 2000; Wang, 2000), 
potentiometric (Barnard, 1968; Ooba, 1991; Richter, 
2003; Sevilla, Alfonso, Andres, 1993; Vreman, 1994; 
Watanabe, 1997) and conductometric (Sevilla, Alfonso, 
Andres, 1993; Yue, Ngin, Hailin, 1996) systems based on 
a multimeter have been described in the literature.
Coupled with optical sensors and transducers, 
the multimeter could constitute a means of measuring 
chemical parameters. Optical sensors are of great interest 
because of their favorable characteristics when compared 
FIGURE 1 - Chemical structure of captopril.
FIGURE 2 - Chemical structure of methyldopa.
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to other kinds of sensors. Portable optical sensors in 
particular are useful for enabling in situ chemical analysis 
(Arnold, 1992; Seitz, Sepaniak, 1988; Wang, 2000).
Moreover, optical sensor-based instruments are 
simple to assemble, low cost, versatile, and can be employed 
in the determination of many chemical parameters with 
promising results. Thus, the objective of this study was 
to describe the application of a portable instrument for 
determination of CPT and MTD in pharmaceutical 
formulations. The results showed good concordance with 
those obtained by the USP standard procedure (USP, 2007) 
for CPT and Brazilian Pharmacopoeia standard procedure 
(Brasil, 2010) for MTD, at a 95% confidence level.
MATERIAL AND METHODS
Apparatus
A prototype of the portable device (Figures 3A and 
3B) was used for all resistance measurements performed 
in this study (Rossi, He, Tubino, 2000). A 9 W Startec desk 
lamp was used as the light source, placed at a distance 
of around 17.0 cm from the cell. A Minipa® ET-1502 
digital multimeter was used to collect the resistance 
measurements. An ordinary glass tube with internal 
diameter of 5.0 mm and length of 50.0 mm was used as 
the sample cell.
Volume measurements were made with a plunger-
operated pipetter (100-1000 µL) and Metrohm model 665 
automatic burettes. All experiments were performed in a 
thermostatically-controlled room (25±1) °C.
Reagents and solutions
All reagents and chemicals used were analytical 
grade and solvents were spectroscopic grade. Deionized 
water was used for the preparation of solutions and 
samples. 
Captopril/p-chloranil/H2O2 system
CPT (reference substance) was purchased from 
Purifarma, São Paulo, Brazil (purity grade > 99.9%, 
calculated on dried basis). CPT characteristics were 
consistent with the United States Pharmacopoeia (USP) 
(USP, 2007). A stock solution (CPTS – 4.65 x 10-3 mol 
l-1) of CPT standard was prepared daily by dissolving 
10.0 mg of the reference substance in methanol 
and diluting to the mark in a 10.0 mL volumetric 
flask. Working standard solutions were obtained by 
appropriate dilution of the stock solution with the 
same solvent and standardized using the standard 
procedure reported in the official method of the USP 
(USP, 2007).
p-Chloranil (Sigma-Aldrich) solution (0.5% w v-1) 
was prepared daily by dissolving 125.0 mg in 25 mL of 
1,4-dioxane (Mallinckrodt - p.a. grade).
H2O2 10.35 mol L-1 (Merck) was standardized 
(Vogel, 1986) by titration with potassium permanganate 
and utilized in the experiments.
Pharmaceutical formulations (tablets) of four 
commercial brands were analyzed. The tablets were 
purchased from local drugstores and all were tested prior to 
the listed expiration date. All pharmaceuticals studied were 
package labeled as containing 25.0 mg of CPT per tablet.
Methyldopa/ammonium molybdate system
Stock 4.65 x 10-3 mol L-1 MTD (Sigma, St. 
Louis, MO, USA, 99.95%) solution was prepared 
daily by dissolving 50.0 mg of the drug in 50.0 mL 
of deionized water. Using a mechanical shaker, the 
powder completely disintegrated after shaking for 15 
minutes. Working standard solutions were obtained 
by appropriate dilution of this stock solution with the 
same solvent and were standardized by the standard 
procedure reported in Brazilian Pharmacopoeia 
(Brasil, 2010).
Ammonium molybdate [(NH4)6.Mo7.O24.4H2O)] 
was purchased from Merck (Darmstadt, Germany, p. a.). 
The ammonium molybdate aqueous solution 1.0% (m v-1) 
was prepared daily.
Pharmaceutical formulations (tablets) of four 
commercial brands were analyzed. These tablets were 
purchased from local drugstores and all were tested prior 
to the listed expiration date. All pharmaceuticals studied 
were package labeled as containing 250 and 500 mg of 
MTD per tablet.
FIGURE 3 - (A) General view of optical device mounted on 
digital multimeter. (B) Schematic diagram of optical device.
P. R. S. Ribeiro, H. R. Pezza, L. Pezza, L. S. Lima, M. Tubino702
Methodology
Captopril/p-chloranil/H2O2 system
•	 Procedure for calibration curve
The calibration curve was constructed by transferring 
800 µL of CPT working standard solutions (comprising 
1.84 x 10-4 to 1.29 x 10-3 mol L-1 of this compound) into 
each series of 5.0 mL standard flasks. A total of 900 µL 
of p-chloranil solution (0.5% w v-1), 225 µL of H2O2 
10.35 mol l-1 and 2 mL of methanol was added to each 
standard flask and left to stand at 50 °C for 30 min 
(Ribeiro, 2011). The blank solution was prepared in a 
similar manner, but omitting the CPT. A constant volume 
of 1200 µL of this solution was introduced into the sample 
cell with micropipette and the resistance measurements 
were obtained against the corresponding reagent blank. 
Calibration graphs were prepared by plotting the electrical 
resistance of the LDR against drug concentration. The 
graphs, or the corresponding linear least squares equations, 
were used to convert the resistance measurement into CPT 
concentration for any given sample analyzed.
•	 Procedure for assay of CPT in pharmaceutical 
samples
Four commercial brands of CPT tablets (A, B, C and 
D) sourced from local drugstores were randomly selected 
and analyzed using the portable electrochemical device. 
For the determination of CPT in pharmaceutical samples, 
twenty tablets were weighed to calculate the average tablet 
weight. Tablets were finely powdered and homogenized. 
A portion of this powder, equivalent to ca. 10.0 mg of 
CPT, was accurately weighed and dissolved in 7 mL of 
methanol by shaking for 15 min on a mechanical shaker. 
The resulting mixture was filtered through Whatman filter 
paper No. 41 into a 10 mL volumetric flask. The filter 
paper was washed using solvent and filtrate. The washing 
was subsequently transferred to a volumetric flask and the 
volume made up to the mark. Aliquots of 1000 µL from 
this solution were transferred into 5.0 mL graduated flasks 
and analyzed according to the recommended procedure 
for the calibration curve. The quantity per tablet was 
calculated from the standard calibration graph.
Methyldopa/ammonium molybdate system
•	 Procedure for calibration curve
A volume of 1000 µL of MTD working standard 
solutions was transferred into each series of 5.0 mL 
standard flasks, comprising 5.04 x 10-4 to 2.52 x 10-3 
mol L-1 of the drug. A total of 1000 µL 2.0% ammonium 
molybdate was added to each graduated flask and the 
volume completed with deionized water (Ribeiro, 2005). 
The blank solution was prepared in a similar manner, 
but omitting the MTD. A constant volume of 1200 µL 
of this solution was introduced into the sample cell with 
micropipette and resistance measurements were obtained 
against the corresponding reagent blank. Calibration 
graphs were prepared by plotting the electrical resistance 
of the LDR against drug concentration. These graphs, or 
the corresponding linear least squares equations, were 
used to convert resistance measurement into captopril 
concentration for any given sample analyzed.
•	 Procedure for assay of MTD in pharmaceutical 
samples 
Four commercial brands of MTD tablets (E, F, G and 
H) sourced from local drugstores were randomly selected 
and analyzed using the portable electrochemical device. 
The average tablet weight was calculated from the contents 
of 20 tablets. Tablets were finely powdered and weighed. 
A portion of this powder, equivalent to ca. 200.0 mg of 
MTD, was accurately weighed and dissolved in 80 mL of 
water by shaking for 15 min on a mechanical shaker. The 
resulting mixture was transferred into 100.0 mL graduated 
flasks and the volume completed with deionized water. 
This solution was clarified by passing it through a cotton 
column filter, rejecting the first 20 mL. Aliquots containing 
equivalent to 1.51 x 10-3 mol L-1 were transferred into 
5.0 mL graduated flasks and analyzed according to the 
recommended procedure for the calibration curve. The 
quantity per tablet was calculated from the standard 
calibration graph. 
Repeatability study (precision)
To examine the repeatability of the measurement 
system, replicate (n = 10) determinations were made for 
the solutions (samples C and F) containing equivalent to 
7.36 x 10-4 mol L-1 of CPT and 1.51 x 10-3 mol L-1 of MTD, 
respectively. These solutions were analyzed according 
to the recommended procedures for the assay of CPT 
and MTD content in pharmaceutical formulations. The 
precisions were calculated in terms of percentage relative 
standard deviation (% RSD).
Accuracy/recovery studies
To study the accuracy of the proposed device 
for the determination of CPT and MTD in the dosage 
forms, recovery experiments were carried out by the 
standard addition method. This study was performed 
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by addition of known amounts (1.66 x 10-4; 1.84 x 10-4; 
2.02 x 10-4 and 2.21 x 10-4 mol L-1 of CPT and 4.54 x 
10-4; 5.04 x 10-4; 5.54 x 10-4 and 6.05 x 10-4 mol L-1 of 
MTD, corresponding to levels of 90; 100; 110 and 120%, 
of these drugs, respectively) of the standard substance 
(pure drugs) to a known concentration of the previously 
analyzed commercial tablets (CPT: samples A, B, C and 
D - MTD: samples E, F, G and H). The resulting mixtures 
were analyzed according to the recommended procedure 
for the assays of CPT and MTD content in pharmaceutical 
formulations. Drug recovery was calculated by comparing 
the concentration obtained from the spiked mixtures with 
those of the pure drugs.
RESULTS AND DISCUSSION
Colorimetry involves the measurement of the 
concentration of chemical species through the amount 
of light absorbed at certain wavelengths. The extent of 
absorption of light is measured based on the intensity of 
the radiation transmitted by the sample solution (Holler, 
2009).
A m u l t i m e t e r  c a n  p e r f o r m  c o l o r i m e t r i c 
measurements when coupled with a photodetector, 
such as a light-dependent resistor (LDR). The LDR is a 
semiconductor whose resistance depends on the intensity 
of the radiation striking its surface. The value of the 
resistance of the sensor (LDR) decreases as the intensity 
of the incident light increases (Rossi, He, Tubino, 2000). 
Thus, for quantitative purposes, calibration curves can 
be obtained by plotting the electrical resistance of the 
LDR (R) against the analyte concentration (C) by a linear 
relationship. In the present study, a multimeter was used 
to measure the resistance of the LDR.
Captopril/p-chloranil/H2O2 system
CPT is a nitrogenous compound that acts as n-donors 
to the π-acceptors. These acceptors react with the basic 
nitrogenous compounds to form charge transfer complexes 
or radical anions according to the polarity of the solvent 
used (Bebawy, 1999). Hence p-chloranil was used in 
this stage of work as the reagent for the determination of 
CPT in the presence of hydrogen peroxide. The addition 
of H2O2 to the reaction medium increases the reaction 
rate (Sawyer, 1991; Mattos et al., 2003). The optimum 
experimental conditions and studies of the stability of this 
product were established in a study previously conducted 
at our laboratory (Ribeiro, 2011). Thus, the experimental 
conditions used in the present study were the same as those 
utilized in the previously tested approach.
The relationship between the electrical resistance 
of the LDR and the concentration of CPT under optimal 
conditions was examined. The analytical curve (Figure 4) 
was obtained by the method of least squares from 
eleven points, each of which was the average of three 
determinations. This curve was obtained by plotting 
the electrical resistance of the LDR against the CPT 
concentration over the range 1.84 x 10-4 to 1.29 x 10-3 mol L-1 
of CPT in the final solution, exhibiting a good coefficient of 
determination (R2 = 0.9946; slope = 1871.0 ± 61.5 L mol-1 
cm-1 and intercept = 0.181 ± 0.033). The limit of detection 
(3.SDblank) (Long, Winefordner, 1983) was 1.54 x 10-5 mol L-1 
of CPT under the experimental conditions described.
The coefficient of determination is not a true 
indicator of linearity, therefore the Fischer variance 
ratio (Araujo, 2009) (test of linearity) was used. The test 
of linearity was performed using the Statistica v. 10.0 
statistical software.
Thus, the test for adequateness of the linearity 
model allows the validity of the regression model and the 
chosen working range to be verified. The ANOVA lack of 
fit model is based on the comparison of the tabulated F of 
Fischer values with the observed F of Fischer calculated 
on the basis of the experimental results, and on the sums 
of squares (Bratinova, Raffael, Simoneau, 2009). On the 
test of linearity, i.e. Fischer variance ratio, the calculated 
value of Flack of fit (Fcal = 0.75) for the analyte was less than 
the tabulated F value (FTab (5,14) = 2.96), indicating linearity 
of response.
Methyldopa/ammonium molybdate system
The reaction of MTD with molybdate ions produces 
a colored water soluble complex (Ribeiro, 2005). The 
absorption spectrum of this reaction product shows 
FIGURE 4 - Analytical curve for determination of CPT.
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that the best analytical wavelength is located at 410 
nm. The optimum experimental conditions and studies 
of the stability of this product were established in a 
study previously conducted at our laboratory. Thus, the 
experimental conditions used in the present study were 
the same as those utilized in the previous study.
The analytical curves were obtained by the method 
of least squares from eleven points, each of which was the 
average of three determinations. This curve (Figure 5) was 
obtained by plotting the electrical resistance of the LDR 
against the MTD concentration over the range 5.04 x 10-4 to 
2.52 x 10-3 mol L-1 of MTD in the final solution, exhibiting 
a good coefficient of determination (R2 = 0.9980; slope = 
1397.2 ± 28.0 L mol-1 cm-1 and intercept = 0.188 ± 0.035). 
The limit of detection (3.SDblank) (Long; Winefordner, 1983) 
was 7.99 x 10-5 mol L-1 of MTD under the experimental 
conditions described. On the test of linearity by the ANOVA 
lack of fit model, the calculated value of Flack of fit (Fcal = 0.53) 
for the analyte was less than the tabulated F value (FTab (5,14) 
= 2.96), indicating linearity of response.
Analytical applications and repeatability studies
In order to assess the utility of the present portable 
device, it was applied to provide an estimation of CPT and 
MTD in commercial tablets. The samples were prepared 
and analyzed according to recommended procedures. The 
measurement system was then successfully applied for 
drug determination in four tablet formulations of these 
drugs. The results, presented in Table I, compare favorably 
with the official methods of the USP for CPT (USP, 2007) 
and of the Brazilian Pharmacopoeia for MTD (Brasil, 
2010), attesting to the applicability of the proposed device 
for the determination of CPT in pharmaceutical dosage 
forms.
Comparing the results obtained using the proposed 
device against those obtained by the official methods, 
based on the Student’s t values (accuracy) and on the F 
test (precision) concordance was observed for the 95% 
(α = 0.05) confidence level (Miller; Miller, 1993). Thus, 
both Student’s t and F tests showed statistical equivalence 
between the results of the proposed device and the 
official methods, thereby attesting to the applicability 
of the proposed device for the determination of drugs in 
pharmaceutical dosage forms.
The RSD values obtained using the proposed device 
for the samples ranged from 0.4 to 1.9% for CPT and 
0.4 to 2.2% for MTD, as shown in Table I. According 
to Horwitz (1982), the maximum RSD value acceptable 
TABLE I - Results of CPT and MTD assays in tablets
Sample Label valuea 
Proposed portable device Official method
Foundb RSD (%)c
t-value 
(2.78)d
F-value 
(19.00)d Found
b RSD 
(%)c
Determination of CPT in commercial pharmaceutical preparations
A 25.0 25.4±0.1 0.4 2.07 1.00 24.9±0.1 0.4
B 25.0 25.6±0.2 0.8 2.52 1.00 24.6±0.2 0.8
C 25.0 25.4±0.2 0.8 2.10 1.00 24.8±0.2 0.8
D 25.0 25.8±0.5 1.9 1.59 2.78 25.2±0.3 1.2
Determination of MTD in commercial pharmaceutical preparations
E 250.0 257.6 ± 1.0 0.4 2.05 1.23 256.3 ± 0.9 0.4
F 250.0 254.0 ± 1.5 0.6 2.69 1.14 258.3 ± 1.6 0.6
G 500.0 510.1 ± 1.0 0.2 0.19 3.24 510.3 ± 1.8 0.4
H 500.0 507.5 ± 11.4 2.2 0.80 1.60 513.9 ± 9.0 1.7
aLabel for content of tablets: mg unit –1. bAverage value ± standard deviation (SD) of three determinations. cRelative standard 
deviation (RSD) of three determinations. dFigures between parentheses are theoretical values of t and F at P = 0.05
FIGURE 5 - Analytical curve for determination of MTD.
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for the working level of the analyte (1.15 x 10-3 mol l-1) 
is 8.0%. The AOAC (1993) set the maximum acceptable 
RSD value at 5.3% for the same analyte level.
The repeatability of the measurement system was 
investigated. The relative standard deviations (RSDs) 
were 1.0% and 1.6% for solutions (n = 10) containing 
CPT and MTD, respectively. These results are evidence 
of good repeatability of the measurement system for drugs 
analysis.
Accuracy/recovery studies
To ascertain the accuracy and precision of the 
portable device, recovery studies were carried out (n = 3) 
by spiking different concentrations of pure drugs in the 
pre analyzed samples with four different concentrations 
of standards within the analytical concentration range of 
the proposed method. The results of the recovery tests 
are given in Table II. The recovery (mean values) for 
TABLE II - Recovery study data for CPT and MTD using proposed device
Drug Sample Added 
(x 10-4 mol l-1)
Found 
(x 10-4 mol l-1)
Recovery 
(%)
CPT A 1.66 
1.84 
2.02 
2.21
1.67 
1.88 
2.00 
2.25
100.6 
102.2 
99.01 
101.8 
µ a = 100.9±1.43
B 1.66 
1.84 
2.02 
2.21
1.63 
1.85 
2.05 
2.20
98.19 
100.5 
101.5 
99.55 
µ a = 99.94±1.41
C 1.66 
1.84 
2.02 
2.21
1.65 
1.85 
2.01 
2.21
99.40 
100.5 
99.50 
100.0 
µ a = 99.86 ± 0.52
D 1.66 
1.84 
2.02 
2.21
1.66 
1.81 
2.04 
2.19
100.0 
98.37 
101.0 
99.10 
µ a = 99.62 ± 1.13
MTD E 4.54 
5.04 
5.54 
6.05
4.50 
5.08 
5.56 
6.01
99.12 
100.8 
100.8 
100.4 
µ a = 100.3±0.79
F 4.54 
5.04 
5.54 
6.05
4.59 
5.10 
5.49 
5.99
101.1 
101.2 
99.10 
99.01 
µ a = 100.1±1.21
G 4.54 
5.04 
5.54 
6.05
4.49 
5.05 
5.48 
6.04
98.89 
100.1 
99.00 
99.95 
µ a = 99.48±0.63
H 4.54 
5.04 
5.54 
6.05
4.61 
4.94 
5.48 
6.12
101.5 
98.09 
98.89 
101.2 
µ a = 99.92±1.68
a Mean ± relative standard deviation (RSD) of three determinations
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samples within the 99.62-100.9% range and RSDs within 
0.52-1.43% for CPT and within the 99.48-100.3% range 
and RSDs within 0.63-1.68% for MTD, confirmed an 
accurate and precise measurement system for application 
to pharmaceutical dosage forms.
CONCLUSION
Based on the above results and from general 
observations in the laboratory, it can be concluded that the 
very simple and portable device proposed by Rossi, He, 
Tubino, (2000) can be used for colorimetric quantitative 
determination of drugs in pharmaceutical preparations. 
Statistical comparison of the results for the portable device 
against those for the official reported methods indicated 
no significant difference in accuracy and precision at a 
95% confidence level . Additionally, the device fulfills all 
the main requirements of routine analysis as it is robust 
and has low instrumentation and operational cost in 
comparison to chromatographic methods.
Thus, the results obtained demonstrate clearly 
demonstrate the potential alternative use of this 
measurement system for the quality control of drugs. 
Moreover, this instrument has applicability for simple, 
accurate, precise, fast, in situ and low-cost colorimetric 
analysis of drugs in pharmaceuticals products.
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